Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2
about
Magnesium in Prevention and TherapyHypomagnesaemia, the kidney and the vesselsMagnesium in CKD: more than a calcification inhibitor?Diabetes is the main factor accounting for hypomagnesemia in obese subjects.Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population.Hypomagnesemia: a clinical perspective.Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.Diabetes mellitus and electrolyte disorders.Risks of rapid decline renal function in patients with type 2 diabetesResults from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney diseaseMagnesium in disease.Association of Serum Magnesium Deficiency with Insulin Resistance in Type 2 Diabetes Mellitus.Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal diseaseProton pump inhibitors are associated with increased risk of development of chronic kidney disease.Low serum magnesium levels are associated with impaired peripheral nerve function in type 2 diabetic patientsSerum magnesium level is associated with type 2 diabetes in women with a history of gestational diabetes mellitus: the Korea National Diabetes Program study.Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation.Clinical features of CKD-MBD in Japan: cohort studies and registry.Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes.Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.The Importance of Magnesium in Clinical Healthcare.Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients.Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients.Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.Serum Magnesium after Kidney Transplantation: A Systematic Review.
P2860
Q26781293-15F29AAF-5ECF-4978-BD2B-9BE360898D99Q26853709-6EF383E1-EC78-4036-9580-411ED3A8C6B3Q27027086-C107C764-6492-4266-9AFA-0A7202D4F5D9Q31047201-FB95E402-A166-4CCE-A90F-8887DCA5B2A2Q31111211-489AE11B-2A56-45EF-BF6A-B7420A79C800Q33774122-EB6E9BE7-9C64-4D68-9EBD-76CD684F6E8CQ33845734-4AAB1E39-3A9A-4D83-9288-36F3BE5FF0E3Q34344884-CC87C742-D56C-4F18-9709-25C42713F14BQ34699197-8620766F-6F18-4A6A-9278-996B05897873Q35243414-5EE9092A-1FB1-40E2-B449-85905CDC5941Q35683765-6C1E963A-B4DC-4500-842B-534F9CF8FA4EQ36026035-41037AF2-6CE6-4A6D-8981-039DF4B222A2Q36047282-7FD9A139-AAC2-4B64-91B1-C4AAD27AC131Q36094152-AD3005B1-405C-4246-BCB4-E304201025D9Q37236893-A01C7ECF-2F34-4932-96B5-D9C1DD3ADA4BQ37473695-FA039E46-0266-40C6-88AC-80C8AD37B072Q38196961-0EB0F1E6-D5D4-495C-9A61-62B34BB9EA65Q38784139-CE217565-6C1F-4401-A92D-A359F9205C63Q39039079-FE57705A-71C8-49CC-9EA5-686CE2A21FACQ40799000-242AA1E9-0B47-4839-BF09-F52ED1BAEBFBQ43131557-ABED2DA1-C7E5-4721-A7C7-5722520A9F04Q47736267-6BF9D052-EC46-4E53-A242-B33E2AE15381Q51496620-968B21D2-4299-45DE-B090-2A1A3511B854Q54963847-811B407A-42FF-454C-890D-DA42ACAFBEC7Q55411384-5097EE9D-46A2-4B47-BCC5-8A73A99D8469Q55447877-AB92F9E8-08EF-4CAA-B687-D8610E8FF8A8
P2860
Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@ast
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@en
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@nl
type
label
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@ast
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@en
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@nl
prefLabel
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@ast
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@en
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@nl
P2093
P3181
P356
P1433
P1476
Lower serum magnesium levels a ...... with diabetes mellitus type 2
@en
P2093
J M Miller
N Yanagawa
P A T Pham
P C T Pham
P M T Pham
P T T Pham
P304
P3181
P356
10.5414/CNP63429
P407
P577
2005-06-01T00:00:00Z